Phenominer Database Results (11 results)

 

Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Record ID Study ID
LH/Mav aorta weight to body weight ratio streptozotocin (75 mg/kg) then perindopril (1 mg/kg/d) (for 56 days) Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. aorta mass male 112.0 days 11 10.1 mg/100g 0.2 0.66 post excision weight measurement 0.0 102690 2703
LH/Mav aorta weight to body weight ratio streptozotocin (75 mg/kg) then hydralazine (75 mg/kg/d) (for 56 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 56 days) and reserpine (0.75 ml/kg/d) (for 56 days) Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. aorta mass male 112.0 days 7 12.5 mg/100g 0.5 1.32 post excision weight measurement 0.0 102691 2703
LH/Mav aorta weight to body weight ratio streptozotocin (75 mg/kg) Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. aorta mass male 112.0 days 14 13.1 mg/100g 0.1 0.37 post excision weight measurement 0.0 102773 2721
LH/Mav aorta weight to body weight ratio controlled sodium content drinking water (2 %) (for 8 days) Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. aorta mass male 119.0 days 7 13.3 mg/100g 0.6 1.59 post excision weight measurement 0.0 103414 2824
LH/Mav aorta weight to body weight ratio perindopril (0.4 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days) Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. aorta mass male 119.0 days 8 12.5 mg/100g 0.6 1.7 post excision weight measurement 0.0 103415 2824
LH/Mav aorta weight to body weight ratio perindopril (1.5 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days) Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. aorta mass male 119.0 days 8 13.6 mg/100g 0.5 1.41 post excision weight measurement 0.0 103416 2824
LH/Mav aorta weight to body weight ratio vehicle control condition Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. aorta mass male 112.0 days 11 13.5 mg/100g 0.2 0.66 post excision weight measurement 0.0 102772 2721
LH/Mav aorta weight to body weight ratio controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) and hydralazine (75 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days) Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. aorta mass male 119.0 days 6 15.7 mg/100g 0.8 1.96 post excision weight measurement 0.0 103417 2824
LH/Mav aorta weight to body weight ratio streptozotocin (75 mg/kg) Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. aorta mass male 112.0 days 8 13.5 mg/100g 0.5 1.41 post excision weight measurement 0.0 102688 2703
LH/Mav aorta weight to body weight ratio controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) and hydralazine (75 mg/kg/d) (for 63 days) and reserpine (0.75 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days) Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. aorta mass male 119.0 days 7 15.8 mg/100g 0.8 2.12 post excision weight measurement 0.0 103418 2824
LH/Mav aorta weight to body weight ratio streptozotocin (75 mg/kg) then perindopril (0.01 mg/kg/d) (for 56 days) Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. aorta mass male 112.0 days 9 12.3 mg/100g 0.4 1.2 post excision weight measurement 0.0 102689 2703